Momordica Charantia Reverses Type Ii Diabetes in Rat Publisher Pubmed



Malekshahi H¹ ; Bahrami G^{1, 2} ; Miraghaee S² ; Ahmadi SA³ ; Sajadimajd S² ; Hatami R² ; Mohammadi B² ; Keshavarzi S² Show Affiliations
Source: Journal of Food Biochemistry Published:2019

Abstract

Diabetes, a disease with abnormal production or use of insulin, is a growing concern that affects many individuals globally. Although many attempts have been made, there is no satisfactory treatment for diabetes. Recently, scientists have been exploring a promising treatment of diabetes involving herbal medicine. In this line, we show that Momordica charantia, a tendril-bearing vine belonging to the Cucurbitaceae family, permanently normalizes blood glucose levels comparable to healthy rats. Most importantly, M. charantia increases the expression of Insulin and Pdx1 genes while lowers the expression Glut2. Moreover, the number and size of the pancreatic islets have remarkably increased in treated animals. Liver ALT, AST, and ALP enzyme activities fell into normal range in treated animals suggesting the protective effect of M. charantia. These data indicate that M. Charantia improves the pancreas function by activating pancreatic beta cells and protecting liver tissue. Practical applications: Owing to the effectiveness of Momordica Charantia extracts in management of diabetes in STZ-induced diabetic rats, we have intention to evaluate the powder of Charantia to discover novel drug for treating diabetes. It is expected that the results could be translated in clinical trials. © 2019 Wiley Periodicals, Inc.